Advances in Oncology

Video Library ADA Guideline Quiz New Guidelines Focus on HER2

Real-World Evidence of CDK4, CDK6 Outcomes

Dr. Stephen Malamud, Mount Sinai
Save to PDF By
Mount Sinai medical oncologist Dr. Stephen Malamud talks about two patient cases that stood out to him in his career.

Featured Video

Emerging New Standard of Care for HER2 Breast Cancer

Emerging New Standard of Care for HER2 Breast Cancer

Stephen Malamud, MD, associate professor of medicine at the Icahn School of Medicine at Mount Sinai in New York, explains the differences in efficacy for various CDK drugs.

© 2024 /alert® unless otherwise noted. All rights reserved.
Reproduction in whole or in part without permission is prohibited.
Privacy Policy | Terms of Use | Editorial Policy | Advertising Policy